Analgesic Solutions is a company that identifies and mitigates errors leading to negative clinical trials. It focuses on regulatory guidance, clinical development strategy, postmarketing surveillance, and other areas. In addition, the company develops QDSS (statistical and predictive analytics-driven central surveillance system to improve assay sensitivity) and MADDERS (standardized system for classifying and quantifying abuse-related events in clinical trials).